Microviable Therapeutics CEO Claudio Hidalgo will be presenting at the 8th International Human Microbiome Consortium Congress 2021 on June 28th. Claudio will discuss the use of “Purified microbiota and LPBs towards the therapeutic applications” and he will showcase preliminary data on the latest in vivo assays with human purified microbiota (HPM).
Claudio will join hundreds of other microbiota scientists, institutions and companies in one of the largest and most prestigious congress of microbiota expecting to attract a large international audience of over 1,000 delegates.
For more information or to meet with us at the conference please contact us
